US EditionNeurocrine Biosciences Appoints Lewis Choi as Chief Information Officer
- Neurocrine Biosciences announced that Lewis Choi will join the company as CIO starting June 9, 2025, as stated in San Diego.
- The appointment follows Neurocrine's ongoing mission to develop treatments for under-addressed neurological and neuropsychiatric disorders.
- Choi brings 25 years of IT and AI experience, including 13 years at Thermo Fisher Scientific in leadership roles driving technological innovation.
- Matt Abernethy, CFO, highlighted Choi's extensive experience in the global healthcare sector and his successful history of leveraging technology to foster both cultural and technological advancements.
- Choi will guide Neurocrine's technology vision to support teams delivering critical treatments, aligning with the advancing pipeline and growing product portfolio.
Insights by Ground AI
Does this summary seem wrong?
17 Articles
17 Articles
All
Left
1
Center
8
Right
Montana Standard+15 Reposted by 15 other sources
Neurocrine Biosciences Appoints Lewis Choi as Chief Information Officer
SAN DIEGO, June 9, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the appointment of Lewis Choi as Chief Information Officer, effective June 9, 2025. Choi, an accomplished leader with 25 years of experience in information technology and…
Coverage Details
Total News Sources17
Leaning Left1Leaning Right0Center8Last UpdatedBias Distribution89% Center
Bias Distribution
- 89% of the sources are Center
89% Center
11%
C 89%
Factuality
To view factuality data please Upgrade to Premium
